Literature DB >> 17122437

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.

Imanuel Dzialowski1, J H Warwick Pexman, Philip A Barber, Andrew M Demchuk, Alastair M Buchan, Michael D Hill.   

Abstract

BACKGROUND AND
PURPOSE: There is ongoing controversy about the impact of hemorrhagic transformation after thrombolysis on long-term functional outcome. We sought to study the relation between the type of hemorrhagic transformation on CT scans and functional outcome.
METHODS: Data were obtained from the Canadian Alteplase for Stroke Effectiveness Study. This study was established as a registry to prospectively collect data for acute stroke patients receiving intravenous alteplase within 3 hours from stroke onset between February 1999 and June 2001. Follow-up was completed at 90 days, and good functional outcome was defined as a modified Rankin Scale score of 0 or 1. Copies of head CT scans obtained at 24 to 48 hours after starting treatment were read in consensus by a central reading panel consisting of 1 neuroradiologist and 1 stroke neurologist. According to European Cooperative Acute Stroke Study criteria, hemorrhagic transformation was classified as none, hemorrhagic infarction (HI-1 and HI-2), or parenchymal hematoma (PH-1 and PH-2). We compared outcome across groups and performed a multivariable analysis including previously determined important predictors of good outcome in acute ischemic stroke.
RESULTS: From 1135 patients enrolled at 60 centers across Canada, 954 follow-up CT scans were assessable. We observed some hemorrhagic transformation in 259 of 954 (27.1%) patients (110 HI-1, 57 HI-2, 48 PH-1, and 44 PH-2). Proportions of patients with good outcome were 41% with no hemorrhagic transformation, 30% with HI-1, 17% with HI-2, 15% with PH-1, and 7% with PH-2 (P<0.0001, chi(2) test). After adjustment for age, baseline serum glucose, baseline Alberta Stroke Program Early CT score, and baseline National Institutes of Health Stroke Scale score, HI-1 was not a predictor of outcome. However, HI-2 (odds ratio=0.38, 95% CI=0.17 to 0.83), PH-1 (odds ratio=0.32, 95% CI=0.12 to 0.80), and PH-2 (odds ratio=0.14, 95% CI=0.04 to 0.48) were all negative predictors of outcome.
CONCLUSIONS: The likelihood of a poor outcome after thrombolysis was proportional to the extent of hemorrhage on CT scans. HI grades of hemorrhagic transformation may not be benign.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122437     DOI: 10.1161/01.STR.0000251644.76546.62

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  49 in total

1.  Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production.

Authors:  Seok Joon Won; Xian Nan Tang; Sang Won Suh; Midori A Yenari; Raymond A Swanson
Journal:  Ann Neurol       Date:  2011-10-14       Impact factor: 10.422

Review 2.  Imaging in acute stroke--a personal view.

Authors:  Thomas Kucinski
Journal:  Klin Neuroradiol       Date:  2009-05-15

3.  Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients.

Authors:  Raul G Nogueira; Rishi Gupta; Tudor G Jovin; Elad I Levy; David S Liebeskind; Osama O Zaidat; Ansaar Rai; Joshua A Hirsch; Daniel P Hsu; Marilyn M Rymer; Ashis H Tayal; Ridwan Lin; Sabareesh K Natarajan; Ashish Nanda; Melissa Tian; Qing Hao; Junaid S Kalia; Michael Chen; Alex Abou-Chebl; Thanh N Nguyen; Albert J Yoo
Journal:  J Neurointerv Surg       Date:  2014-01-08       Impact factor: 5.836

4.  Postischemic hyperperfusion on arterial spin labeled perfusion MRI is linked to hemorrhagic transformation in stroke.

Authors:  Songlin Yu; David S Liebeskind; Sumit Dua; Holly Wilhalme; David Elashoff; Xin J Qiao; Jeffry R Alger; Nerses Sanossian; Sidney Starkman; Latisha K Ali; Fabien Scalzo; Xin Lou; Bryan Yoo; Jeffrey L Saver; Noriko Salamon; Danny J J Wang
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

5.  Lower serum calcium level is associated with hemorrhagic transformation after thrombolysis.

Authors:  Yang Guo; Shenqiang Yan; Sheng Zhang; Xiaocheng Zhang; Qingmeng Chen; Keqin Liu; David S Liebeskind; Min Lou
Journal:  Stroke       Date:  2015-03-26       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke: calculation of dose based on estimated patient weight can increase the risk of cerebral bleeding.

Authors:  Andrés García-Pastor; Fernando Díaz-Otero; Carmen Funes-Molina; Beatriz Benito-Conde; Sandra Grandes-Velasco; Pilar Sobrino-García; Pilar Vázquez-Alén; Yolanda Fernández-Bullido; Jose Antonio Villanueva-Osorio; Antonio Gil-Núñez
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

7.  Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.

Authors:  Jaspreet Kaur; Ursula I Tuor; Zonghang Zhao; Philip A Barber
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-25       Impact factor: 6.200

8.  Improving acute stroke management with computed tomography perfusion: a review of imaging basics and applications.

Authors:  C D d'Esterre; Enrico Fainardi; R I Aviv; T Y Lee
Journal:  Transl Stroke Res       Date:  2012-05-24       Impact factor: 6.829

Review 9.  Hemorrhagic transformation after ischemic stroke in animals and humans.

Authors:  Glen C Jickling; DaZhi Liu; Boryana Stamova; Bradley P Ander; Xinhua Zhan; Aigang Lu; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-27       Impact factor: 6.200

Review 10.  Extending the Time Window for Endovascular and Pharmacological Reperfusion.

Authors:  Nils Henninger; Marc Fisher
Journal:  Transl Stroke Res       Date:  2016-01-07       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.